FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310175356> ?p ?o ?g. }

• W4310175356 endingPage "177" @default.
• W4310175356 startingPage "166" @default.
• W4310175356 abstract "Background: Irritable bowel syndrome (IBS) is a disorder that causes stomach pain in children and adolescents. It may also impact one's quality of life. IBS is linked to gastrointestinal issues such as diarrhoea and constipation. Despite the identification of several potential pathophysi-ological pathways, the aetiology of IBS remained unknown Objective: The aim of this paper is to discuss the diagnosis, pathogenesis, case studies and treatment of Irritable bowel syndrome in children and adolescents. Method: This systematic review covered relevant papers from the previous ten years that were accessible in Science Direct, Elsevier, NCBI, and Web of Science related to the pathophysiology and function of pharmacological drugs such as antidepressants, antispasmodics, prokinetics, and antibiotics in children with irritable bowel syndrome. Result: those have been demonstrated to be effective. This article presents case studies including 50-59 children, which demonstrate a favourable acceptable impact that is more effective than a pla-cebo in terms of reducing symptoms and improving the overall quality of life in children who have irritable bowel syndrome. Furthermore, the majority of the pathophysiological explanations and treatment options discussed are based on adult studies. These major issues arose when treating paediatric IBS, and they must be addressed in order to properly treat children with IBS. Trials that focus on many combinations of pharmacological and non-pharmacological therapies seem to be more helpful. Discussion: In recent years, a number of systematic reviews have been conducted to evaluate the efficacy of medication treatments in children for IBS; however, the dependability of these systemat-ic reviews needs to be further investigated owing to the various experimental designs and levels of evidence used. This article highlights paediatric therapy options, including pharmaceutical medica-tions such as antidepressants, antispasmodics, prokinetics, and antibiotics. The goal is to alleviate IBS symptoms while also enhancing the quality of life for children with this illness." @default.
• W4310175356 created "2022-11-30" @default.
• W4310175356 creator A5002488768 @default.
• W4310175356 creator A5020755842 @default.
• W4310175356 creator A5028797814 @default.
• W4310175356 creator A5029235719 @default.
• W4310175356 creator A5029772279 @default.
• W4310175356 creator A5037189486 @default.
• W4310175356 date "2024-05-01" @default.
• W4310175356 modified "2023-10-14" @default.
• W4310175356 title "Children and Adolescents with Irritable Bowel Syndrome: Treatment and Management" @default.
• W4310175356 doi "https://doi.org/10.2174/1573396319666221128094843" @default.
• W4310175356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36443973" @default.
• W4310175356 hasPublicationYear "2024" @default.
• W4310175356 type Work @default.
• W4310175356 citedByCount "0" @default.
• W4310175356 crossrefType "journal-article" @default.
• W4310175356 hasAuthorship W4310175356A5002488768 @default.
• W4310175356 hasAuthorship W4310175356A5020755842 @default.
• W4310175356 hasAuthorship W4310175356A5028797814 @default.
• W4310175356 hasAuthorship W4310175356A5029235719 @default.
• W4310175356 hasAuthorship W4310175356A5029772279 @default.
• W4310175356 hasAuthorship W4310175356A5037189486 @default.
• W4310175356 hasConcept C118552586 @default.
• W4310175356 hasConcept C126322002 @default.
• W4310175356 hasConcept C137627325 @default.
• W4310175356 hasConcept C159110408 @default.
• W4310175356 hasConcept C177713679 @default.
• W4310175356 hasConcept C2778188384 @default.
• W4310175356 hasConcept C2778271842 @default.
• W4310175356 hasConcept C2779951463 @default.
• W4310175356 hasConcept C2781112942 @default.
• W4310175356 hasConcept C71924100 @default.
• W4310175356 hasConceptScore W4310175356C118552586 @default.
• W4310175356 hasConceptScore W4310175356C126322002 @default.
• W4310175356 hasConceptScore W4310175356C137627325 @default.
• W4310175356 hasConceptScore W4310175356C159110408 @default.
• W4310175356 hasConceptScore W4310175356C177713679 @default.
• W4310175356 hasConceptScore W4310175356C2778188384 @default.
• W4310175356 hasConceptScore W4310175356C2778271842 @default.
• W4310175356 hasConceptScore W4310175356C2779951463 @default.
• W4310175356 hasConceptScore W4310175356C2781112942 @default.
• W4310175356 hasConceptScore W4310175356C71924100 @default.
• W4310175356 hasIssue "2" @default.
• W4310175356 hasLocation W43101753561 @default.
• W4310175356 hasLocation W43101753562 @default.
• W4310175356 hasOpenAccess W4310175356 @default.
• W4310175356 hasPrimaryLocation W43101753561 @default.
• W4310175356 hasRelatedWork W1987166490 @default.
• W4310175356 hasRelatedWork W2061253126 @default.
• W4310175356 hasRelatedWork W2132613885 @default.
• W4310175356 hasRelatedWork W2973152183 @default.
• W4310175356 hasRelatedWork W3035664070 @default.
• W4310175356 hasRelatedWork W3200968936 @default.
• W4310175356 hasRelatedWork W4285038855 @default.
• W4310175356 hasRelatedWork W4318197161 @default.
• W4310175356 hasRelatedWork W4386082807 @default.
• W4310175356 hasRelatedWork W2302789613 @default.
• W4310175356 hasVolume "20" @default.
• W4310175356 isParatext "false" @default.
• W4310175356 isRetracted "false" @default.
• W4310175356 workType "article" @default.